Massachusetts General Hospital
- Consultant: Abbott Laboratories; AstraZeneca LP; Eli Lilly and Company; Euthymics; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institute on Drug Abuse; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Grant Support: Abbott Laboratories; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institute on Drug Abuse; Shire Pharmaceuticals Inc.
- Has been a speaker : Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Royalties: Guilford Press